Appili Therapeutics Inc
Research Appili Therapeutics Inc (APLI) on Bullrun: market cap CAD 1.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAPLI
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 1.99M
- Financial periodQ1 2026
- RevenueCAD 25.26K
- Net income-CAD 1.05M
- Free cash flow-CAD 291.85K
Valuation Snapshot
latest market cap is CAD 1.99M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 206.31K | -CAD 2.96M | -CAD 11.33K | n/a | n/a | CAD 212.75K | CAD 12.46M | -CAD 16.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CAD 1.99M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Appili Therapeutics Inc
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Appili Therapeutics Inc's market cap?
Appili Therapeutics Inc's market capitalization is CAD 1.99M.
What does Appili Therapeutics Inc do?
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections.